Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate in elderly adults, the safety and reactogenicity of repeated vaccination with FluAS25, during 21 days following the intramuscular administration of the vaccine. Fluarix administered to young (19-41 years) and elderly (>/= 66 years) adults will be used as reference.
Critère d'inclusion
- Immunisation against influenza disease in an elderly population aged over 65 years